SCHEMBL23809103

SCHEMBL23809103

Cc1cccc(Cn2cc(C(=O)O)c3cccc(C(C)C)c32)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ABCC4 O15439 1/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
PTGS1 P23219 1/20 0.38
ACKR3 P25106 1/20 0.38
NR3C1 P04150 1/20 0.37
SLC22A12 Q96S37 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
MCL1 Q07820 2/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
SORT1 Q99523 1/20 0.35
MAPT P10636 1/20 0.35
BRD4 O60885 1/20 0.35
BAD Q92934 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809352 0.82 KDM4E (0.43) KDM4EMEN1KMT2ASLC22A12PTGES2
SCHEMBL23809500 0.81 MCL1 (0.39) KDM4EMEN1KMT2ALMNANR3C1
SCHEMBL23809168 0.76 KDM4E (0.49) KDM4ELMNAALDH1A1L3MBTL1TSHR
SCHEMBL1022698 0.74 LMNA (0.63) MEN1KMT2AABCC4LMNAPKM
SCHEMBL23809280 0.74 CNR1 (0.45) KDM4EMEN1KMT2AMCL1MAPT
SCHEMBL23809505 0.73 KDM4E (0.56) KDM4EMEN1KMT2ASLC22A12MAPT
SCHEMBL23809344 0.72 NOTUM (0.40) KDM4EKMT2ALMNAPTGS1PTGES2
SCHEMBL31023004 0.72 MCL1 (0.38) KDM4EMEN1KMT2APTGES2MCL1
SCHEMBL26581454 0.71 KDM4E (0.66) KDM4EMEN1KMT2ALMNASLC22A12
SCHEMBL14535539 0.70 CNR2 (0.58) LMNAACKR3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KDM4E 1156/4885MEN1 3549/4885KMT2A 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.